---
authors:
- Fang, Serena
- Sharifian, Roya
- Cheng, Vivian
- Neher, Jon O
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/40106294/
file_path: 2025/03/zuranolone-zurzuvae-for-treatment-of-severe-postpartum-depre.md
issue: '3'
keywords:
- Depression
last_updated: '2025-07-30'
original_format: PubMed
pages: 265-266
patient_population: Adults
peer_reviewed: true
pmid: '40106294'
processed_date: '2025-07-30'
publication_date: '2025-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Zuranolone (Zurzuvae) for Treatment of Severe Postpartum Depression in Adults.
topics:
- Depression
- Psychiatry
- Family Medicine
- Mental Health
volume: '111'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '40106294'
  title: Zuranolone (Zurzuvae) for Treatment of Severe Postpartum Depression in Adults.
  authors:
  - last_name: Fang
    fore_name: Serena
    initials: S
    affiliation: Valley Family Medicine, Renton, Washington.
  - last_name: Sharifian
    fore_name: Roya
    initials: R
    affiliation: Valley Family Medicine, Renton, Washington.
  - last_name: Cheng
    fore_name: Vivian
    initials: V
    affiliation: Valley Family Medicine, Renton, Washington.
  - last_name: Neher
    fore_name: Jon O
    initials: JO
    affiliation: Valley Family Medicine, Renton, Washington.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '111'
    issue: '3'
  publication_info:
    year: '2025'
    month: '03'
    full_date: '2025-03-01'
  article_ids: {}
  publication_types: *id001
related_articles:
- pmid: '40106294'
  title: Zuranolone (Zurzuvae) for Treatment of Severe Postpartum Depression in Adults.
  authors:
  - name: Fang S
    authtype: Author
    clusterid: ''
  - name: Sharifian R
    authtype: Author
    clusterid: ''
  - name: Cheng V
    authtype: Author
    clusterid: ''
  - name: Neher JO
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2025 Mar
- pmid: '38387651'
  title: Zuranolone, a neuroactive drug, used in the treatment of postpartum depression
    by modulation of GABA(A) receptors.
  authors:
  - name: Sharma R
    authtype: Author
    clusterid: ''
  - name: Bansal P
    authtype: Author
    clusterid: ''
  - name: Saini L
    authtype: Author
    clusterid: ''
  - name: Sharma N
    authtype: Author
    clusterid: ''
  - name: Dhingra R
    authtype: Author
    clusterid: ''
  source: Pharmacol Biochem Behav
  pubdate: 2024 May
- pmid: '38133592'
  title: Zuranolone (Zurzuvae) - An oral drug for postpartum depression.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2023 Dec 25
- pmid: '37882942'
  title: 'Zuranolone: First Approval.'
  authors:
  - name: Heo YA
    authtype: Author
    clusterid: ''
  source: Drugs
  pubdate: 2023 Nov
- pmid: '38768648'
  title: First Oral Treatment Specific for Postpartum Depression.
  authors:
  - name: Blakely KK
    authtype: Author
    clusterid: ''
  source: Nurs Womens Health
  pubdate: 2024 Aug
---

# Zuranolone (Zurzuvae) for Treatment of Severe Postpartum Depression in Adults.

**Authors:** Fang, Serena, Sharifian, Roya, Cheng, Vivian, Neher, Jon O

**Published in:** American family physician | Vol. 111, No. 3 | 2025-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/40106294/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Depression, Psychiatry, Family Medicine, Mental Health

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/40106294/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
